Gemmus Pharma Secures $3,300,000 Series B Funding

  • Feed Type
  • Date
    5/13/2014
  • Company Name
    Gemmus Pharma
  • Mailing Address
    409 Illinois Avenue San Francisco, CA 94158 USA
  • Company Description
    Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus’ lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza.
  • Website
    http://www.gemmuspharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,300,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company intends to use the funds to complete production and toxicology studies for an IND filing by the end of the year.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy